Effect of Intratumoral Injection of Gene Therapy for Locally Advanced Pancreatic Cancer

NCT02806687 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

DRUG: Gene Therapy product CYL-02
DRUG: Gemcitabine

Sponsor

University Hospital, Toulouse

Collaborators

[object Object]
[object Object]